Autopsy report · NCT03698045
Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.
Cause of deathFunding or business, also staffing, sites or logistics
“the clinical study was canceled by the sponsor due to logistics and programming”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1
- Sponsor
- Laboratorios Sophia S.A de C.V.
- Sponsor type
- Industry
- Conditions
- Conjunctivitis, Bacterial
- Interventions
- PRO-143 Ophthalmic Solution
- Participants
- 0
- Sites
- 1
- Countries
- Mexico
Trials that died the same way
- Observational Study to Assess Migraine Prediction Tool
“The Sponsor decided to cancel the study due to commercial considerations” - Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
“Study was cancelled by Sponsor.” - Study of Select Combinations in Adults With Myelofibrosis
“This study was cancelled before enrolling any patients for business related reasons.” - The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-up Study
“Due to difficulty in recruiting patients, the Sponsor decided to prematurely stop the study” - RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
“The sponsor's clinical program for the agent used in this study was discontinued.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.